BerandaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
$0,91
Rentang hari
$0,87 - $0,93
Rentang tahun
$0,65 - $2,45
Kapitalisasi pasar
35,50Â jt USD
Volume Rata-Rata
34,78Â rb
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 20,30Â jt | 250,87% |
Laba bersih | -19,65Â jt | -26,85% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,49 | -22,50% |
EBITDA | -18,26Â jt | -14,94% |
Tarif pajak efektif | 0,11% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 99,12Â jt | -23,74% |
Total aset | 142,00Â jt | -28,82% |
Total liabilitas | 26,40Â jt | -3,87% |
Total ekuitas | 115,59 jt | — |
Saham yang beredar | 40,27 jt | — |
Harga terhadap nilai buku | 0,32 | — |
Tingkat pengembalian aset | -33,57% | — |
Tingkat pengembalian modal | -37,64% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,65Â jt | -26,85% |
Kas dari operasi | -14,90Â jt | -26,05% |
Kas dari investasi | -5,00Â rb | 98,38% |
Kas dari pembiayaan | 2,00Â rb | -99,60% |
Perubahan kas bersih | -11,82Â jt | 2,46% |
Arus kas bebas | -10,07Â jt | -72,81% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
105
